AHA Scientific Sessions 2023 Late-Breaking Science Coverage

Published: 30 October 2023

  • Views:

    Views Icon 2001
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.

 

In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of cardiovascular innovation, they offer concise perspectives on late-breaking data.

 

Dr Harriette Van Spall returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.

 

Watch our Expert interviews for late-breaking science methodology, results and implications for practice and research in under 10 minutes.

 

Delve into the personal motivations of some of the investigators, and gain valuable insights and advice for early career researchers in our Behind the Heart series. These short videos offer an opportunity to look beyond scientific achievements and connect on a more personal level.

More from this programme

Part 1

View from the Thoraxcenter

In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. 

Part 2

Late-Breaker Discussions with Harriette Van Spall

Dr Harriette Van Spall, recipient of 2022's AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.

About the episode

AHA 23 - We are joined by Dr Demilade Adedinsewo (Mayo Clinic, US) to discuss the findings from a study investigating the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population.

In the intervention arm, the digital stethoscope correctly identified 92% of those with ejection fraction <50% and 100% of those with ejection fraction <40% .

Questions
1. What are the unmet needs for patients with pregnancy-related cardiomyopathy?
2. What was the patient population and study design?
3. What were your key findings?
4. What are your take-home messages?
5. What further research is needed, and what are the next steps?

Recorded on-site at AHA Scientific Sessions 2023, Philadelphia.

Support: This is an independent interview conducted by Radcliffe Cardiology.

Interviewer: Mirjam Boros
Editor: Jordan Rance
Video Specialist: 

Faculty Biographies

Demilade Adedinsewo

Demilade Adedinsewo

Dr Demilade Adedinsewo, a general non-invasive cardiologist, is dedicated to advancing women's heart health, cardiovascular disease prevention, and addressing cardiovascular health disparities. With a keen interest in leveraging digital tools for effective cardiovascular disease management, Dr. Adedinsewo currently holds the esteemed position of Mayo Clinic Florida Women's Health Scholar.

In her role, Dr Adedinsewo serves as the Director of Research for both the Women's Heart Clinic and the Cardiovascular Disease Fellowship program. Beyond clinical practice, she passionately advocates for heart health and collaborates closely with the American Heart Association, contributing to initiatives focused on cardiovascular disease awareness and health education.

Dr Adedinsewo's diverse interests span women's heart disease, general cardiology, echocardiography, cardiovascular epidemiology, and the application of digital tools for cardiovascular disease detection. Her commitment…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.